Vir tus He alth (ASX. VRT ) Annual Ge ne r al Me e ting We dne sday 9th Nove mbe r 2016 2.00pm AE DT
DISCL AIME R 2 T he ma te ria l in this pre se nta tio n ha s b e e n pre pa re d b y Virtus He a lth L imite d ABN 80 129 643 492 (“Virtus He a lth”) a nd is g e ne ra l b a c kg ro und info rma tio n a b o ut Virtus He a lth’ s a c tivitie s c urre nt a t the da te o f this pre se nta tio n. T he info rma tio n is g ive n in summa ry fo rm a nd inc lude s fina nc ia l a nd o the r info rma tio n a nd do e s no t purpo rt to b e c o mple te . Info rma tio n in this pre se nta tio n, inc luding fo re c a st fina nc ia l info rma tio n sho uld no t b e c o nside re d a s a dvic e o r a re c o mme nda tio n to inve sto rs o r po te ntia l inve sto rs a nd do e s no t ta ke into a c c o unt inve stme nt o b je c tive s, fina nc ia l situa tio n o r ne e ds o f a ny pa rtic ula r inve sto r. T he se sho uld b e c o nside re d, with o r witho ut pro fe ssio na l a dvic e whe n de c iding if a n inve stme nt is a ppro pria te . Pe rso ns ne e ding a dvic e sho uld c o nsult the ir sto c kb ro ke r, so lic ito r, a c c o unta nt o r o the r inde pe nde nt fina nc ia l a dviso r. T he re le a se , pub lic a tio n o r distrib utio n o f this pre se nta tio n in c e rta in jurisdic tio ns ma y b e re stric te d b y la w a nd the re fo re pe rso ns in suc h jurisdic tio ns into whic h this pre se nta tio n is re le a se d, pub lishe d o r distrib ute d sho uld info rm the mse lve s a b o ut a nd o b se rve suc h re stric tio ns. T his pre se nta tio n do e s no t c o nstitute , o r fo rm pa rt o f, a n o ffe r to se ll o r the so lic ita tio n o f a n o ffe r to sub sc rib e fo r o r b uy a ny se c uritie s, no r the so lic ita tio n o f a ny vo te o r a ppro va l in a ny jurisdic tio n, no r sha ll the re b e a ny sa le , issue o r tra nsfe r o f the se c uritie s re fe rre d to in this pre se nta tio n in a ny jurisdic tio n in c o ntra ve ntio n o f a pplic a b le la w. Ce rta in sta te me nts ma de in this pre se nta tio n a re fo rwa rd-lo o king sta te me nts. T he se fo rwa rd- lo o king sta te me nts a re no t histo ric a l fa c ts b ut ra the r a re b a se d o n Virtus He a lth L imite d’ s c urre nt e xpe c ta tio ns, e stima te s a nd pro je c tio ns a b o ut the industry in whic h Virtus He a lth o pe ra te s, a nd b e lie fs a nd a ssumptio ns. Wo rds suc h a s “a ntic ipa te s”, “e xpe c ts”, “inte nds,”, “pla ns”, “b e lie ve s”, “se e ks”, “e stima te s”, a nd simila r e xpre ssio ns a re inte nde d to ide ntify fo rwa rd-lo o king sta te me nts. T he se sta te me nts a re no t g ua ra nte e s o f future pe rfo rma nc e a nd a re sub je c t to kno wn a nd unkno wn risks, unc e rta intie s a nd o the r fa c to rs, so me o f whic h a re b e yo nd the c o ntro l o f Virtus He a lth, a re diffic ult to pre dic t a nd c o uld c a use a c tua l re sults to diffe r ma te ria lly fro m tho se e xpre sse d o r fo re c a ste d in the fo rwa rd-lo o king sta te me nts. Virtus He a lth c a utio ns inve sto rs a nd po te ntia l inve sto rs no t to pla c e undue re lia nc e o n the se fo rwa rd-lo o king sta te me nts, whic h re fle c t the vie w o f Virtus He a lth o nly a s o f the da te o f this pre se nta tio n. T he fo rwa rd-lo o king sta te me nts ma de in this pre se nta tio n re la te o nly to e ve nts a s o f the da te o n whic h the sta te me nts a re ma de . Virtus He a lth will no t unde rta ke a ny o b lig a tio n to re le a se pub lic ly a ny re visio ns o r upda te s to the se fo rwa rd-lo o king sta te me nts to re fle c t e ve nts, c irc umsta nc e s o r una ntic ipa te d e ve nts o c c urring a fte r the da te o f this pre se nta tio n e xc e pt a s re q uire d b y la w o r b y a ny a ppro pria te re g ula to ry a utho rity. A numb e r o f fig ure s, a mo unts, pe rc e nta g e s, e stima te s, c a lc ula tio ns o f va lue a nd fra c tio ns in this pre se nta tio n a re sub je c t to the e ffe c t o f ro unding . Ac c o rding ly, the a c tua l c a lc ula tio n o f the se fig ure s ma y diffe r fro m the fig ure s se t o ut in this pre se nta tio n. In a dditio n, a numb e r o f fig ure s ha ve b e e n c a lc ula te d o n the b a sis o f a ssume d e xc ha ng e ra te s, a s se t o ut in this pre se nta tio n. T o the ma ximum e xte nt pe rmitte d b y la w, ne ithe r Virtus He a lth no r its re la te d b o die s c o rpo ra te , dire c to rs, o ffic e rs, e mplo ye e s, a g e nts, c o ntra c to rs, a dvise rs no r a ny o the r pe rso n, a c c e pts, a nd e a c h e xpre ssly disc la ims, a ny lia b ility, inc luding witho ut limita tio n a ny lia b ility a rising fro m fa ult o r ne g lig e nc e , fo r a ny e rro rs o r missta te me nts in, o r o missio ns fro m, this pre se nta tio n o r a ny dire c t, indire c t o r c o nse q ue ntia l lo ss a rising fro m the use o f this pre se nta tio n o r its c o nte nts o r o the rwise a rising in c o nne c tio n with it.
CE O Pr e se ntation Sue Channon
VIRT US HE AL T H NE T WORK OF CARE 6 Gra ph title
One c hild in e ve ry Austra lia n c la ssro o m… 7
Y CARE VIRT US HE AL T H - WORL D L E ADE R IN F E RT IL IT 8 Mar ke t le ade r and lar ge st pr o vide r o f fe r tility se r vic e s in Austr alia and Ir e land with a gr o wing pr e se nc e in Singapo r e One of the la rg e st fe rtility pra c tic e s g loba lly • Re puta tion for c linic a l a nd sc ie ntific e xc e lle nc e • T hre e pilla rs : F e rtility, Da y Hospita l a nd Spe c ia lise d Dia g nostic s • Strong F ina nc ia l tra c k re c ord of re ve nue a nd E BIT DA g rowth • F ull ye a r divide nd o f 28 c e nts pe r sha re • * T o ta l tre a tme nts inc lude fre sh c yc le s, fro ze n e mb ryo tra nsfe rs a nd IUI s
SOL ID F INANCIAL T RACK RE CORD 9 Re por te d E BIT DA NPAT Pr e - minor itie s Re porte d Re ve nue Gra ph title 261 35 69 234 31 30 201 187 172 61 59 20 56 52 10 F Y12 F Y13 F Y14 F Y15 F Y16 F Y12 F Y13 F Y14 F Y15 F Y16 F Y12 F Y13 F Y14 F Y15 F Y16 No te : Cha rts a re o n a re po rte d b a sis. NPAT pre mino ritie s.
IONS IRISH F E RT IL IT Y OPE RAT 10 Ir e land de live r s str o ng c yc le and e ar nings gr o wth Ma inta ins le a de rship po sitio n with E BI T DA g ro wth o f 32.8% • T hre e c linic s : Sims I VF & Ro tunda I VF (“RI VF ”) in Dub lin & Sims I VF in Co rk • 2,321 c yc le s pe rfo rme d in F Y16 a c ro ss a ll I rish o pe ra tio ns (F Y15: 1,878) • IRE T re a tme nt numb e rs inc re a se d 31.3% to 3,688 (F Y15: 2,809) • 8.1% c o ntrib utio n to g ro up se g me nt E BI T DA up fro m 6.0% F Y 15 •
IONS SINGAPORE F E RT IL IT Y OPE RAT 11 Singapo r e c yc le s inc r e asing – po sitive E BIT DA pe r fo r manc e Po sitive E BI T DA la st fo ur mo nths o f F Y16 • SNG 301 c yc le s pe rfo rme d in Sing a po re in F Y16 (F Y15: 86) • T re a tme nt numb e rs inc re a se d to 664 (F Y15: 160) • Clinic a l suc c e ss a nd pa tie nt c a re ha s b uilt a stro ng re puta tio n • E xpe c t to se e furthe r impro ve me nt in F Y17 with e xpa nde d c linic a l te a m • o f c o ntra c te d a nd a sso c ia te d spe c ia lists
ION AUST RAL IAN F E RT IL IT Y OPE RAT 12 Vir tus r e mains mar ke t le ade r in an e xpanding mar ke t with inc r e ase d c o mpe tition Re po rte d se g me nt E BI T DA inc re a se d 3.8% to $71.2m • Ab so lute c yc le numb e rs inc re a se d 6.6% to 16,097 c yc le s • T re a tme nt numb e rs inc re a se d 10.6% to 29,917 (F Y15: 27,056) • Go o d o rg a nic g ro wth in full se rvic e fe rtility c linic s • T F C me tro sub due d with stro ng T F C re g io na l g ro wth dua l b ra nd • o ffe ring Re c o g nise d b ra nds re g a rde d fo r q ua lity a nd se rvic e • Ong o ing inve stme nt in a dva nc e d sc ie nc e s a nd spe c ia lise d dia g no stic s • de live rs impro ve d pa tie nt o utc o me s a nd re ve nue g ro wth
S AUST RAL IAN DIAGNOST ICS & DAY HOSPIT AL 13 Diagno stic r e ve nue inc r e ase d Day ho spital r e ve nue in line 5.1% F Y16 with F Y15 Ac q uisitio n & inte g ra tio n o f I DS Mo de st g ro wth in re ve nue in 5 o f 6 • • Ca te g o ry G Pa tho lo g y L a b Da y Ho spita ls Re ve nue o ptimisa tio n a c ro ss ARS • I VF re ve nue in o ur Da y Ho spita ls • va lue c ha in inc re a se d 3% Drive re ve nue fro m g e ne tic te sting • Pro c e dura l mix e xpa nsio n / no n-I VF • c a pa b ility pro c e dure g ro wth Drive e ffic ie nc y •
F ACT ORS DRIVING GROWT H 14 De mog ra phic & soc ia l tre nds • Adva nc e me nts in te c hnolog y • E volution of c linic a l pra c tic e & se rvic e de live ry • Inte rna tiona l dive rsific a tion •
F ACT ORS DRIVING GROWT H – Soc ial T re nds 15
F ACT ORS DRIVING GROWT H – Advanc e d T e c hnology 16 Studying the c hr omosomal Se le c ting the he althie st Using time lapse imaging str uc tur e of e ggs spe r m to study e mbr yo gr owth
Recommend
More recommend
